Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor

Documenti analoghi

• Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level
  di: Song, De-Gang, et al.
  Pubblicazione: (2016)
• High affinity FRβ-specific CAR T cells eradicate AML and normal yeloid lineage without HSC toxicity
  di: Lynn, Rachel C, et al.
  Pubblicazione: (2016)
• A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity
  di: Song, De-Gang, et al.
  Pubblicazione: (2015)
• Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor–expressing T cells
  di: Lynn, Rachel C., et al.
  Pubblicazione: (2015)
• In vivo persistence, tumor localization and anti-tumor activity of CAR engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB)
  di: Song, De-Gang, et al.
  Pubblicazione: (2011)